Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Diabetic Kidney Disease (China)
CTR20160415Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finerenone in diabetic glomerulosclerosis, type 2 diabetes mellitus (T2DM), sponsored by Bayer. Started Aug 2016; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20160415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160415.